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Improving The Quality Of Consent To Randomised Controlled
Trials Using Continuous Consent And Clinician Training In The
Consent Process
ABSTRACT
Objectives: To assess whether continuous consent, a process
whereby information is given to research participants at different
stages in a trial, plus clinician training in that process was effective
when used by clinicians gaining consent to the TOBY trial. The TOBY
trial is a randomised controlled trial investigating the use of whole
body cooling for neonates with evidence of perinatal asphyxia.
Obtaining valid informed consent for TOBY is difficult; as such, it is a
good test of the effectiveness of continuous consent.
Methods: Semi-structured interviews were conducted with 30 sets of
parents who gave consent to TOBY and with 10 clinicians who sought
it using the continuous consent process. Analysis focused on the
validity of parental consent based upon the consent components of
competence, information, understanding and voluntariness.
Results: 19/27 (70%) couples had no significant problems with
consent validity at the point of signature. Problems lay mainly with
the parents’ competence and understanding. Mothers particularly
had competence problems in the early stages of consent. The
understanding problems were primarily to do with side effects.
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Problems in both areas (competence and understanding) reduced
markedly, particularly for mothers, in the post signature phase when
further discussion took place. Randomisation was generally
understood but unpopular. Clinicians did not always give information
in stages during the short period of time available before parents gave
consent. However, most clinicians were able to give follow up
information.
Discussion: The consent validity compares favourably with similar
trials examined in a comparable study (the Euricon study).
Conclusion: Researchers should consider adopting elements of the
continuous consent process and clinician training in RCTs,
particularly where they have concerns about the quality of consent
they are likely to obtain using a conventional process.
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INTRODUCTION
The TOBY-QUAL study aimed to evaluate the process of continuous
consent used during the MRC funded TOBY trial. TOBY is a
randomised controlled trial (i.e. a research study in which patients are
allocated at random to receive one of two or more clinical
interventions) in which babies born with evidence of perinatal
asphyxia are randomised either to receive conventional care or
conventional care plus whole body cooling (to 34oC) on a special
mattress for 72 hours. It presents a challenge for clinicians to obtain
valid, informed consent from parents of neonates for at least three
reasons: first, the trial involves very sick infants; second, the trial
treatment needs to be started within six hours of birth; and third,
treatment is not blind, even to the parents, and yet babies in the
control group born away from specialist treatment centres will need to
be transferred to one of these centres. The stress for parents is
compounded by the fact that perinatal asphyxial encephalopathy is
almost always unexpected. Such circumstances threaten the validity
of consent (1, 2).
The continuous consent approach to obtaining informed consent for
RCTs has been proposed as a method for ameliorating this difficulty
(3). It involves giving parents information at more than one point in
the trial in the hope that they will assimilate it better. Such an
approach is used in the TOBY trial. It has three main elements (4):
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Element 1: If born in a non-cooling centre, while the baby is assessed
for eligibility, parents are given preliminary information about the
trial, including a preliminary information leaflet. (If deemed
appropriate, the leaflet may also be given to parents of babies born in
a cooling centre or preliminary information may be offered more
informally.)
Element 2: If the baby is eligible, a second, more comprehensive,
information leaflet is given to the parents and further discussion takes
place. At this point, parents are asked for their written consent and
randomised.
Element 3: During the intervention period the consultant
neonatologist meets with the parents to ensure that they understand
the trial procedures and wish to continue to participate in the trial. It
is made clear that the parents remain free to withdraw their baby from
the trial.
In addition, clinicians are given training in obtaining informed consent
for TOBY and at all times, a senior investigator is available to discuss
concerns raised by parents during the trial. As the trial took place
during the critical opening 72 hours of the neonate’s life, the
availability of a senior investigator (who was also a senior clinician
involved in the baby’s care) was fairly reliable although there may
have been some delay at times (e.g. in the middle of the night).
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Continuous consent aims to obtain the best possible informed consent
in a situation of urgency. However, it has not been evaluated. The
objective of ‘TOBY-QUAL’, the qualitative sub-study reported here, was
to evaluate the process of continuous consent used in TOBY.
METHODS
One researcher (PA) conducted semi-structured interviews with
parents who gave their consent to the TOBY trial and clinicians who
sought it using the above process. The interview questions were open-
ended and based around the four components of informed consent:
competence, information, understanding and voluntariness (5). The
transcripts were analysed using a well-established, qualitative process
(framework analysis) (6). The validity of consent was assessed against
the four components of the consent listed above. A scoring system
was used on each component as follows:
1 = perfect
2 = valid with minor problems
3 = equivocal: significant problems
4 = validity in doubt: serious problems with the standard.
A score was given for each parent both for the point at which they
gave formal signed consent and for the point at which they had
further discussion with the clinician after the signature but during the
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treatment phase. These scores were then assimilated and an overall
score was given first, for each parent and then for the couple as a
whole. The interviews were also analysed with a view to discerning
common themes.
Determining in which category to place the components involved
judging the interviews against the criteria for informed consent that
has developed across a wide range of ethical and legal literature. For
example, the Re. C UK legal judgement gives several criteria by which
to judge competence (7). Thus, were a mother to have received opiates
to the extent that she were no longer able fully to retain the necessary
information to give informed consent then this would be deemed
either a significant or a serious problem (depending on how impaired
she was). In a similar way, we would judge parents to have a problem
with understanding if, for example, they were unable to give a
description of how treatment was randomly assigned. To ensure
reliability of analysis, the two investigators analysed each interview
independently.
RESULTS
Background data
Between January 2003 and July 2004, there were 55 eligible TOBY-
QUAL babies. Five sets of parents were excluded: one because of poor
English, the rest because the consultant asked us not to approach the
parents. In all these cases the baby had died and the consultant felt
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it inappropriate to approach the parents, for example, because he or
she thought it would be unduly upsetting to talk about the study.
The remaining 50 were asked to take part in TOBY-QUAL. 20 refused
or did not respond to the request; 30 were interviewed. Of the parents
interviewed, the split between those whose babies received the trial
treatment and control was 17/13. 4/30 (13%) interviews were with
the mother alone, the rest with both parents. In all but one case, both
parents were available to give consent to TOBY. Ten clinicians were
interviewed. Demographic information is provided in table I.
Use of the continuous consent process
Many parents did not recall the process being used precisely as set
out above (Table II). The first information sheet is envisioned mainly
for use when babies are to be transferred from an outlying hospital; as
such, its absence was not considered a deviation from the continuous
consent process if it was not given in cooling centres. We deemed
more significant any deviations from elements 2 or 3. Overall, the
process was followed fully in 17 cases, mostly in seven, but was not
followed in six cases.
Validity of consent
At the point of signature, the overall consent validity for the couple,
taking the best score of either parent was as follows: 19/27 (70%) had
a validity score of 1 or 2 (i.e. perfect or with minor problems); 8/27
(30%) had a validity score of 3 or 4 (i.e. significant or serious
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problems). For three sets of parents there were missing data for the
father (e.g. where the mother was interviewed alone).
A key finding was the improvement in consent validity at signature to
that post signature for each parent (Table III). At signature 22/30
(73%) of mothers and 8/27 (30%) of fathers had significant or serious
problems with the validity of their consent. In the post signature
phase (element 3) the respective figures were 7/29 (24%) and 4/26
(15%) (data missing from four sets of parents). Thus there was a
general improvement for both mothers and fathers from element 2 to
element 3 of the consent process. This was more marked for mothers,
perhaps because they had the greater problem in the first place.
19/29 (66%) of mothers showed an improvement as against 9/26
(35%) of fathers. Taking each consent component in more detail:
A) Competence: See Table IV. 18/30 (60%) mothers had impaired
competence (scored 3 or 4) at signature. This was due largely to the
anaesthesia, opiates and other problems associated with a traumatic
birth.
“I just, I really can’t remember anything at the time; … I
was smacking myself on the nose to keep myself awake
because I was just like this [gestures sleepy] my head
was spinning; most of the day is a blur anyway, most of
the labour’s a blur … they give you morphine…”
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[Mother: 24] (The interview number at the end of each
quote shows the variety of sources used.)
However, fathers were able to compensate; all but one father (whose
first language was not English) scored 1 or 2 for competence at the
point of signature. Nonetheless, some fathers did find consent
difficult due to factors such as the speed and suddenness of events
combined with the emotional trauma. Where fathers were more
competent at the time of signature they usually signed the consent
form. On a few occasions less competent mothers were asked to sign
because the couple weren’t married. One unmarried father signed on
behalf of his incompetent partner. The competence of the mothers
generally improved in the post-signature phase and they were usually
able to play an active role in the third element of the continuous
consent process.
B) Information: See Table IV. The main problem in the pre-signature
phase was that 4/30 (13%) sets of parents did not recall receiving a
main information sheet. In the post signature phase, 6/30 (20%) did
not recall receiving follow up information although in half of these
cases the baby died (and, therefore, follow up information would have
been inappropriate).
C) Understanding: See Table IV. At the point of signature 19/30
(63%) mothers and 7/27 (26%) fathers had poor understanding
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(scored 3 or 4). In the post signature phase there was a marked
improvement: the respective figures were 10/29 (34%) and 5/26
(19%). The problems of understanding for the mothers seemed largely
to result from their competence problems. However, a number of
themes emerged across the range of parents.
1) Treatment. Following element 3 of the consent process, almost
all parents grasped the general idea of whole body hypothermia,
the procedure and its basic rationale. The main reason parents
gave for their consent was the hope that trial entry would improve
their baby’s prospects. One or two also mentioned the hope that
it would contribute to future knowledge.
2) Side effects. The main TOBY information sheet says the
following:
“…there is a possibility that cooling may lead to
problems with blood pressure control, abnormal heart
rhythm, bleeding and clotting problems and chemical
and sugar imbalances in the blood.”
Some clinicians highlighted this point (whilst others said they
played down the side effects). Table V summarises the parental
awareness of side effects. Surprisingly up to 48% of parents
interviewed, despite being given the main information sheet (and
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usually verbally informed about side effects) did not seem to have
knowledge of them at interview. 6/30 (11%) did not recall being
informed of side effects (e.g. some said they were explicitly told
that there were none, others did not recall being given the main
information sheet). Some parents said that they only gave
consent because they believed that the treatment could not harm
the baby.
“Our main concern was whether it would have side
effects, that was our main concern; any side effects and
we wouldn’t have given our consent.” [Father: 11]
For other parents, the situation may have seemed so severe that
side effects were of little import to them.
“We fully understood what he wanted to do in terms of
treatment … we fully understood the side effects if there
was going to be any, or the risks involved, but obviously
whatever anyone tells you all you listen to is that your
child is damaged…” [Mother: 2]
3) Randomisation. In 3/30 (10%) interviews it seemed that the
parents had not grasped the fact that treatment would be chosen
randomly. For example, one parent thought it was used in order
to allocate a scarce resource. In the remaining interviews at least
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one parent in each couple had a reasonable understanding of
randomisation. However, many parents disliked the method.
Generally, those who received control were disappointed whilst
those who received cooling were relieved.
“I remember saying to him, ‘Oh great, great, like some
effing placebo’ is what I said to him; so, no, I totally
understood that idea, so I was kind of glad [because the
baby received cooling.]” [Mother: 4]
D) Voluntariness. See table IV. Clinicians showed concern about the
voluntariness of parents’ consent:
“… it’s easy for someone to put a gun to your head and
say it’s your decision. And the gun being that their
baby is born and is damaged and is needing a lot of
resuscitation and here we are saying, look there’s a trial
happening and this is the only thing available, and
there’s nothing else available…” [Clinician: 6]
And it was certainly something many parents spoke about:
“Interviewer: What made you say yes?
Father: Desperation, I suppose, there was no other option
and it was worth a shot, and that is the truth.” [Father:
15]
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Nonetheless, only two parents had a significant or serious problem in
relation to voluntariness; the vast majority of parents were clear that
the decision was theirs, that normal treatment was available outside
the trial and that they could withdraw. Some parents mentioned this
withdrawal option as a reason for giving their consent in the first
place. Thus voluntariness seems to have been achieved at the point of
signature despite the short period of time available and the
desperation of the parents.
Attitudes to the consent process
26/27 (96%) sets of parents said they felt it was right that clinicians
sought their consent for the trial (missing data from three sets of
parents). Some parents talked of their right to decide on behalf of
their child. Other parents said that being asked for consent enabled
them to feel involved in their child’s care, perhaps for the first time.
Clinicians also generally viewed consent as valuable or necessary.
However, at least two pointed to the scientific cost involved in delaying
randomisation and trial entry whilst obtaining consent.
Only two parents noted problems with the use of continuous consent
itself. Both related to receiving additional information at a later stage.
For example, one father said,
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“We were told a hell of a lot more on the [element 3 stage] than we
were on the [element 2, day of birth].” [Father:10]
DISCUSSION
Interpretation of the study requires discussion of its limitations. First,
we relied on the memory of participants, which may be flawed (8).
This problem applies to any interview-based study of a phenomenon.
It is obviated in our study by the fact that 12/30 (40%) interviews
were conducted within one month of the baby’s birth, and 22/30
(73%) within three months; all were conducted within 12 months.
Furthermore, flawed memory should, if anything, worsen the results
because parents, for example, lose their understanding of
randomisation. Therefore, flawed memory does not undermine our
generally positive findings on continuous consent.
Perhaps it might be argued that interviewees were inclined to give a
positive assessment of the consent process as the immediate memory
faded, particularly in the presence of a kindly interviewer; a type of
Hawthorne effect. However, three points make this unlikely. First,
many of our questions probed objective measures, such as knowledge
of randomisation; a kindly interviewer cannot create this knowledge.
Second, parents were willing to criticise elements of the consent
process, particularly randomisation. Third, it would be odd for there
to be a Hawthorne effect in the TOBY-QUAL study that was not
Continuous consent
17
present in the many other studies of consent to RCTs that found
poorer quality consent.
Another limitation relates to our sample. Twenty sets of parents
either declined or did not respond to our interview request. There
were a higher proportion of deaths in the non-respondent group (40%
against 13%). However, one should bear in mind that many of the
babies that survived were impaired to varying degrees. Their parents
would not necessarily have a particularly rosy view of the TOBY trial
compared with those whose babies died. Another issue is that we
interviewed only parents who gave consent to TOBY. There were some
parents who refused it. Our reason for excluding this group is that
they did not go through the continuous consent process and,
therefore, could not comment on it.
TOBY-QUAL’s chief aim was to judge whether or not the standardised,
continuous consent process used in the TOBY trial was successful at
getting valid informed consent from parents. The time available for
consent is short and the research is looking at a treatment for a life
threatening condition in the neonate. The Euricon study (1)
interviewed 30 sets of parents who had given consent to similar
studies. In the Euricon study, at the point of signature, there were
significant or serious problems with consent validity in at least 17/30
(57%) cases. (This is the lowest possible estimate; it may have been
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higher.) The equivalent figure in the TOBY trial is 8/27 (30%) parents:
this is a marked improvement on the Euricon figures. It suggests that
TOBY clinicians using the continuous consent process had done well
in difficult circumstances. Perhaps more importantly, in the post-
signature phase (element 3) the validity scores often improved,
particularly for mothers. This is one of the successes of continuous
consent. With conventional consent procedures, mothers whose
competence is impaired up to the point of signature can be sidelined
from consent, with continuous consent they are not.
What explains this relative success? In the first place, TOBY trial
clinicians were offered training and support in the process of
obtaining consent (including role-play and workshops). The success
in obtaining a relatively good quality of consent at the point of
signature is presumably partly down to this training and partly down
to element 1 (formal or informal) and element 2. The improvement
post signature shows the benefit of the formal follow-up discussion
(element 3) and, presumably, again the training of clinicians.
This has implications for other trials. Numerous empirical studies
have uncovered a poor standard of informed consent to RCTs (9, 10,
11). It is tempting to conclude that valid informed consent cannot be
obtained, particularly in difficult situations (12). TOBY shows that
careful attention to consent can, at least to some extent, overcome the
difficulties. Researchers should consider using aspects of the
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continuous consent process particularly where they believe that
obtaining valid informed consent might be difficult.
One such aspect is formal training of researchers in obtaining
informed consent. Presently, clinicians have very little, if any, such
training (3). This may change as ethics and communication enter
medical curricula. However, the training for clinicians in the TOBY
trial is geared specifically at gaining informed consent for that trial;
such an approach could be more helpful than a generic one.
A second aspect is treating informed consent as a process rather than
a point (i.e. the point where a signature is given). This
recommendation has been made before (13). In TOBY it is done
through graded information (element 1, followed by element 2) prior to
signed consent and formal follow-up discussion (element 3). We found
element 3 to be most helpful to mothers who are unwell after the
birth. As such it might be of particular use where consent is obtained
from people with acute illnesses. However, many of the fathers also
seemed to benefit from the follow-up; hence its use should not
necessarily be restricted to the acutely ill. Element 1 may be
particularly helpful in non-urgent situations where there is a lot of
complex information to convey.
Another factor researchers might take from the TOBY trial is the
attitude to informed consent. The decision to use continuous consent
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was a reflection of the fact that the trial investigators viewed consent
as important; much attention was paid to the design of the process;
clinicians were trained in its use. Some of the positive findings of this
study, such as the overwhelming voluntariness of parental consent,
may reflect the attitude of the clinicians to consent as much as the
process itself. Overall, the TOBY-QUAL study suggests that a process
view of consent, reflected in a design such as continuous consent, can
help clinicians obtain valid informed consent.
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Appendix: Flow chart of continuous consent process
Baby born in treatment
centre
Baby born outside
treatment centre
Element 1
Baby assessed for
eligibility. At same time,
parents given
preliminary information
and, if appropriate,
preliminary information
Element 1
Baby assessed for
eligibility. At same time,
Parents given
preliminary information
and preliminary
information sheet.
Element 2
If eligible, parents given second, longer
information sheet and the trial is discussed with
them. They are then asked for written consent.
This must be given within six hours of birth if the
baby is to be admitted to the trial.
Element 3
During the intervention period (72 hours after birth)
the consultant neonatologist meets with the parents
to ensure that they understand the trial procedures
and wish to continue to participate in the trial. It is
made clear that the parents remain free to withdraw
their baby from the trial.
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Table I: Social class, ethnicity and age of parents
Social class1 Ethnicity2 Age
Mother Father Mother Father
1 – Higher managerial and
professional
1 White UK 24 19 16-19 1 0
2 – Lower managerial and
professional
8 White other 2 6 20-29 9 5
3 – Intermediate
occupations
3 Pakistani 1 1 30-39 18 17
4- Small employers and
own account workers
2 Black Caribbean 1 0 40+ 1 5
5 – Lower supervisory and
technical
5 Black African 2 3 Not known 1 3
6 – Semi-routine
occupations
2 Not known 0 1 Total number 30 30
7 – Routine occupations 5 Total number 30 30
8 – Never worked/ long
term unemployed
3
Not known 1
Total number 30
1 Based on Office of National Statistics Classification [www.statistics.gov.uk – accessed 30/5/05].
2 Based on Office of National Statistics Classification [www.statistics.gov.uk – accessed 30/5/05]. Ethnic groups not represented were: mixed, Indian,
Bangladeshi, Other Asian, Other Black, Chinese, Other Ethnic.]
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Table II Was the continuous consent process followed?
Element 1
First sheet given separately (transferral centre) 5
First sheet given separately (cooling centre) 3
First sheet given with main information sheet (cooling and transfer centres) 12
First information sheet not remembered being given (transferral centre) 3
First information sheet not remembered being given (cooling centre) 7
Element 2
Main information sheet given with discussion 26
Main information sheet given after signed consent 1
Main information sheet not remembered being given but discussion took place 3
Element 3
Follow up discussion took place 24
No follow up discussion remembered (baby died) 3 [all in control group]
No follow up discussion remembered (baby lived) 3 [2 in control group]
Continuous consent in the TOBY trial.
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Table III: Consent validity at signature and post signature for each parent, plus validity improvement post
signature
Mother FatherValidity score
At signature Post signature At signature Post signature
1- Perfect 0 8 3 9
2- Minor Probs 8 14 16 13
3- Significant Probs 12 3 5 2
4- Serious Probs 10 4 3 2
Don’t know 0 1 3 4
Total Number 30 30 30 30
Improved post signature 19 9
Stayed the same post signature 10 17
No information 1 4
Total Number 30 30
Table IV: Validity of individual components At sign and Post sign signature for each parent
Competence Information Understanding Voluntariness
Mother Father Mother Father Mother Father Mother Father
Validity score
At
Sign
Post
sign
At
sign
Post
sign
At
sign
Post
sign
At
sign
Post
sign
At
sign
Post
sign
At
sign
Post
sign
At
sign
Post
sign
At
sign
Post
sign
1 – Perfect 3 24 13 22 20 23 21 23 1 8 5 8 23 27 22 25
2 – Minor problems 9 3 12 2 4 1 3 0 10 11 15 13 6 2 4 1
3 – Significant
problems
10 2 1 1 3 2 1 1 9 6 4 3 0 0 1 1
4 – Serious problems 8 0 0 0 3 3 2 2 10 4 3 2 1 1 0 0
Don’t know 0 1 4 5 0 1 3 4 0 1 3 4 0 0 3 3
Total number 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30
Continuous consent in the TOBY trial.
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Table V Parental recall of side effects of total body cooling (55 parents of 30 babies)
Aware of side effects before signing consent form 19 (34%)
Aware of side effects after signing consent form 4 (7%)
Side effects not acknowledged although clearly informed about them (e.g. had read main
information sheet)
18 (33%)
Not aware of side effects although given main information sheet (but this had not been read) 8 (15%)
Not properly informed of side effects 6 (11%)
Total Number 55
